Getting it right: Recommendations for a European BARDA
EPHA #A2MDialogues

8 December 2020

16:00-17:00 CET


Our fifth dialogue in a series of online discussions on key access to medicines (A2M) priorities bringing together thought leaders and policy-makers, academics, industry representatives and NGOs, for a frank discussion of European pharmaceutical policies.

Take part in our #A2MDialogues to share your questions and ideas and help us develop actionable #A2Msolutions for decision-makers in Europe. 

Will the EU be a wise investor in biomedical R&D or a passive donor?

How can we guarantee a public return on public investment? 

As the EU considers establishing an Agency comparable to the U.S. Biomedical Advanced Research and Development Authority (BARDA), we will outline a set of recommendations on how to get it right.




Marie-Paule Kieny

Director of Research


Michel Goldman

Founder, I3h Institute

Former IMI Executive Director


Moderated by

Yannis Natsis

Policy Manager, Universal Access and Affordable Medicines

European Public Health Alliance

Join our panelists to discuss 

How do we guarantee an EU Barda which does not simply fix market failures but steers meaningful innovation driven by public health needs?

How do we ensure we have an EU Barda whose governance is transparent & inclusive?


How do we ensure an EU biomedical research agency will promote new business models and prioritise the affordability of all end products?

Catch up on EPHA’s other #A2MDialogues below

The Presidencies’ perspective on the pharmaceutical strategy: Europe’s to-do list on access to medicines

25 November 2020

Pharma & COVID19: Winners, losers, prospects

19 November  2020

The EU's IP strategy: Enabler or barrier?

27 October 2020

Unleashing meaningful innovation through regulatory reform

19 October 2020

Follow on social media




Yannis Natsis

Policy Manager, Universal Access and Affordable Medicines, EPHA

Get involved !

Get involved !

Sign up here to receive our updates on European health policy and invitations to our events.

Subscribe now

You have Successfully Subscribed!